BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dale E, Bang-andersen B, Sánchez C. Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochemical Pharmacology 2015;95:81-97. [DOI: 10.1016/j.bcp.2015.03.011] [Cited by in Crossref: 123] [Cited by in F6Publishing: 111] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Serrano-contreras JI, García-pérez I, Meléndez-camargo ME, Zepeda-vallejo LG. NMR-based metabonomic analysis of normal rat urine and faeces in response to (±)-venlafaxine treatment. Journal of Pharmaceutical and Biomedical Analysis 2016;123:82-92. [DOI: 10.1016/j.jpba.2016.01.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
2 Salagre E, Grande I, Solé B, Sanchez-Moreno J, Vieta E. Vortioxetine: A new alternative for the treatment of major depressive disorder. Rev Psiquiatr Salud Ment (Engl Ed) 2018;11:48-59. [PMID: 28800937 DOI: 10.1016/j.rpsm.2017.06.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
3 Khadrawy YA, Sawie HG, Hosny EN, Mourad HH. Assessment of the antidepressant effect of caffeine using rat model of depression induced by reserpine. Bull Natl Res Cent 2018;42. [DOI: 10.1186/s42269-018-0034-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kim EJ, Felsovalyi K, Young LM, Shmelkov SV, Grunebaum MF, Cardozo T. Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues. Psychopharmacology (Berl) 2018;235:2643-50. [PMID: 29961917 DOI: 10.1007/s00213-018-4958-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Griesi-Oliveira K, Suzuki AM, Muotri AR. TRPC Channels and Mental Disorders. Adv Exp Med Biol 2017;976:137-48. [PMID: 28508319 DOI: 10.1007/978-94-024-1088-4_12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Ramanuj P, Ferenchick EK, Pincus HA. Depression in primary care: part 2-management. BMJ. 2019;365:l835. [PMID: 30962249 DOI: 10.1136/bmj.l835] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
7 Feng HJ, Faingold CL. Abnormalities of serotonergic neurotransmission in animal models of SUDEP. Epilepsy Behav 2017;71:174-80. [PMID: 26272185 DOI: 10.1016/j.yebeh.2015.06.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
8 Mikkelsen K, Hallam K, Stojanovska L, Apostolopoulos V. Yeast based spreads improve anxiety and stress. Journal of Functional Foods 2018;40:471-6. [DOI: 10.1016/j.jff.2017.11.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
9 du Jardin KG, Müller HK, Elfving B, Dale E, Wegener G, Sanchez C. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2016;71:27-38. [DOI: 10.1016/j.pnpbp.2016.05.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
10 Wada T, Sameshima A, Yonezawa R, Morita M, Sawakawa K, Tsuneki H, Sasaoka T, Saito S. Impact of central and peripheral estrogen treatment on anxiety and depression phenotypes in a mouse model of postmenopausal obesity. PLoS One 2018;13:e0209859. [PMID: 30589890 DOI: 10.1371/journal.pone.0209859] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
11 Arancibia S, Marambio M, Campusano JM, Fierro A. Modeling of the Binding of Octopamine and Dopamine in Insect Monoamine Transporters Reveals Structural and Electrostatic Differences. ACS Chem Neurosci 2019;10:2310-7. [PMID: 30605598 DOI: 10.1021/acschemneuro.8b00631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Słupski J, Cubała WJ, Górska N, Gałuszko-Węgielnik M, Wiglusz MS. Role of copper in depression. Relationship with ketamine treatment. Med Hypotheses 2018;119:14-7. [PMID: 30122482 DOI: 10.1016/j.mehy.2018.07.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Puryear CB, Brooks J, Tan L, Smith K, Li Y, Cunningham J, Todtenkopf MS, Dean RL, Sanchez C. Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? Neuroscience & Biobehavioral Reviews 2020;108:658-78. [DOI: 10.1016/j.neubiorev.2019.12.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
14 Elkhatib SK, Case AJ. Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease. Pharmacol Res 2019;146:104293. [PMID: 31176794 DOI: 10.1016/j.phrs.2019.104293] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
15 Targum SD, Cameron BR, Ferreira L, MacDonald ID. An augmentation study of MSI-195 (S-adenosylmethionine) in Major Depressive Disorder. J Psychiatr Res 2018;107:86-96. [PMID: 30368163 DOI: 10.1016/j.jpsychires.2018.10.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
16 Yoshimura Y, Ishikawa C, Kasegai H, Masuda T, Yoshikawa M, Shiga T. Roles of 5-HT1A receptor in the expression of AMPA receptor and BDNF in developing mouse cortical neurons. Neurosci Res 2017;115:13-20. [PMID: 27702575 DOI: 10.1016/j.neures.2016.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
17 Wang H, Tong Y, Xiao D, Xia B. Involvement of mTOR-related signaling in antidepressant effects of Sophoraflavanone G on chronically stressed mice. Phytother Res 2020;34:2246-57. [PMID: 32246575 DOI: 10.1002/ptr.6675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hao C, Gao Z, Liu X, Rong Z, Jia J, Kang K, Guo W, Li J. Intravenous administration of sodium propionate induces antidepressant or prodepressant effect in a dose dependent manner. Sci Rep 2020;10:19917. [PMID: 33199803 DOI: 10.1038/s41598-020-77085-z] [Reference Citation Analysis]
19 Feng P, Akladious AA, Hu Y. Hippocampal and motor fronto-cortical neuroligin1 is increased in an animal model of depression. Psychiatry Res 2016;243:210-8. [PMID: 27423632 DOI: 10.1016/j.psychres.2016.06.052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
20 Brummelte S, Galea LA. Postpartum depression: Etiology, treatment and consequences for maternal care. Horm Behav 2016;77:153-66. [PMID: 26319224 DOI: 10.1016/j.yhbeh.2015.08.008] [Cited by in Crossref: 185] [Cited by in F6Publishing: 161] [Article Influence: 30.8] [Reference Citation Analysis]
21 Oved K, Farberov L, Gilam A, Israel I, Haguel D, Gurwitz D, Shomron N. MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action. Front Mol Neurosci 2017;10:355. [PMID: 29163031 DOI: 10.3389/fnmol.2017.00355] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
22 Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU. Five potential therapeutic agents as antidepressants: a brief review and future directions. Expert Rev Neurother 2015;15:1015-29. [PMID: 26312645 DOI: 10.1586/14737175.2015.1071192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kalinichenko L, Kornhuber J, Müller C. Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders. Frontiers in Neuroendocrinology 2019;55:100783. [DOI: 10.1016/j.yfrne.2019.100783] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
24 Singh T, Goel RK. Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities. Neurochem Res 2021;46:1305-21. [PMID: 33665775 DOI: 10.1007/s11064-021-03274-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Wang Q, Dwivedi Y. Advances in novel molecular targets for antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2021;104:110041. [PMID: 32682872 DOI: 10.1016/j.pnpbp.2020.110041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Sheng J, Liu S, Wang Y, Cui R, Zhang X. The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plast 2017;2017:9724371. [PMID: 28706741 DOI: 10.1155/2017/9724371] [Cited by in Crossref: 133] [Cited by in F6Publishing: 118] [Article Influence: 33.3] [Reference Citation Analysis]
27 Gao Y, Li X, Zhao HL, Ling-Hu T, Zhou YZ, Tian JS, Qin XM. Comprehensive Analysis Strategy of Nervous-Endocrine-Immune-Related Metabolites to Evaluate Arachidonic Acid as a Novel Diagnostic Biomarker in Depression. J Proteome Res 2021;20:2477-86. [PMID: 33797260 DOI: 10.1021/acs.jproteome.0c00940] [Reference Citation Analysis]
28 Jia E, Bartlett MG. Recent advances in liquid chromatographic methods for the determination of selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors. Biomedical Chromatography 2020;34. [DOI: 10.1002/bmc.4760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
29 Gao Y, Mu J, Xu T, Linghu T, Zhao H, Tian J, Qin X. Metabolomic analysis of the hippocampus in a rat model of chronic mild unpredictable stress-induced depression based on a pathway crosstalk and network module approach. J Pharm Biomed Anal 2021;193:113755. [PMID: 33190083 DOI: 10.1016/j.jpba.2020.113755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 McNeal N, Watanasriyakul WT, Normann MC, Akinbo OI, Dagner A, Ihm E, Wardwell J, Grippo AJ. The negative effects of social bond disruption are partially ameliorated by sertraline administration in prairie voles. Auton Neurosci 2019;219:5-18. [PMID: 31122602 DOI: 10.1016/j.autneu.2019.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Gómez-canela C, Rovira García X, Martínez-jerónimo F, Marcé RM, Barata C. Analysis of neurotransmitters in Daphnia magna affected by neuroactive pharmaceuticals using liquid chromatography-high resolution mass spectrometry. Environmental Pollution 2019;254:113029. [DOI: 10.1016/j.envpol.2019.113029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
32 Strasser B, Gostner JM, Fuchs D. Mood, food, and cognition: role of tryptophan and serotonin. Curr Opin Clin Nutr Metab Care 2016;19:55-61. [PMID: 26560523 DOI: 10.1097/MCO.0000000000000237] [Cited by in Crossref: 68] [Cited by in F6Publishing: 38] [Article Influence: 13.6] [Reference Citation Analysis]
33 Colzato L, Zhang W, Walter H, Beste C, Stock AK. An Oppositional Tolerance Account for Potential Cognitive Deficits Caused by the Discontinuation of Antidepressant Drugs. Pharmacopsychiatry 2021. [PMID: 34293810 DOI: 10.1055/a-1520-4784] [Reference Citation Analysis]
34 Lam CS, Tipoe GL, Wong JK, Youdim MB, Fung ML. M30 Antagonizes Indoleamine 2,3-Dioxygenase Activation and Neurodegeneration Induced by Corticosterone in the Hippocampus. PLoS One 2016;11:e0166966. [PMID: 27870896 DOI: 10.1371/journal.pone.0166966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Descalzi G, Mitsi V, Purushothaman I, Gaspari S, Avrampou K, Loh YE, Shen L, Zachariou V. Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression. Sci Signal 2017;10:eaaj1549. [PMID: 28325815 DOI: 10.1126/scisignal.aaj1549] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 16.0] [Reference Citation Analysis]
36 Koura SM, Salama M, El-Hussiny M, Khalil MEA, Lotfy A, Hassan SA, Gad Elhak SA, Sobh MA. Fluoxetine induces direct inhibitory effects on mesenchymal stem cell‑derived osteoprogenitor cells independent of serotonin concentration. Mol Med Rep 2019;19:2611-9. [PMID: 30720108 DOI: 10.3892/mmr.2019.9924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Morris PJ, Moaddel R, Zanos P, Moore CE, Gould TD, Zarate CA Jr, Thomas CJ. Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites. Org Lett 2017;19:4572-5. [PMID: 28829612 DOI: 10.1021/acs.orglett.7b02177] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
38 Bernaskova K, Tomkova S, Slamberova R. Are changes in excitability in the hippocampus of adult male rats induced by prenatal methamphetamine exposure or stress? Epilepsy Res 2017;137:132-8. [PMID: 28886886 DOI: 10.1016/j.eplepsyres.2017.08.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
39 Moragrega I, Ríos JL. Medicinal Plants in the Treatment of Depression: Evidence from Preclinical Studies. Planta Med 2021;87:656-85. [PMID: 33434941 DOI: 10.1055/a-1338-1011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Khadrawy YA, Sawie HG, Abdel-salam OM, Hosny EN. Cannabis exacerbates depressive symptoms in rat model induced by reserpine. Behavioural Brain Research 2017;324:41-50. [DOI: 10.1016/j.bbr.2017.02.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
41 Schneider KE, Dayton L, Wilson D, Nestadt PS, Latkin CA. Distress in the time of COVID-19: Understanding the distinction between COVID-19 specific mental distress and depression among United States adults. J Affect Disord 2021;294:949-56. [PMID: 34375223 DOI: 10.1016/j.jad.2021.07.095] [Reference Citation Analysis]
42 Abildgaard A, Elfving B, Hokland M, Wegener G, Lund S. Probiotic treatment reduces depressive-like behaviour in rats independently of diet. Psychoneuroendocrinology 2017;79:40-8. [PMID: 28259042 DOI: 10.1016/j.psyneuen.2017.02.014] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 20.5] [Reference Citation Analysis]
43 Fasipe OJ. The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents. IBRO Rep 2019;6:95-110. [PMID: 31211282 DOI: 10.1016/j.ibror.2019.01.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
44 Gao TT, Wang Y, Liu L, Wang JL, Wang YJ, Guan W, Chen TT, Zhao J, Jiang B. LIMK1/2 in the mPFC Plays a Role in Chronic Stress-Induced Depressive-Like Effects in Mice. Int J Neuropsychopharmacol 2020;23:821-36. [PMID: 32827213 DOI: 10.1093/ijnp/pyaa067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Wang SM, Han C, Lee SJ, Jun TY, Patkar AA, Masand PS, Pae CU. Efficacy of antidepressants: bias in randomized clinical trials and related issues. Expert Rev Clin Pharmacol 2018;11:15-25. [PMID: 28893095 DOI: 10.1080/17512433.2017.1377070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
46 Fahmy HM, Khadrawy YA, Abd-El Daim TM, Elfeky AS, Abd Rabo AA, Mustafa AB, Mostafa IT. Thymoquinone-encapsulated chitosan nanoparticles coated with polysorbate 80 as a novel treatment agent in a reserpine-induced depression animal model. Physiol Behav 2020;222:112934. [PMID: 32353367 DOI: 10.1016/j.physbeh.2020.112934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Foley PB. Dopamine in psychiatry: a historical perspective. J Neural Transm 2019;126:473-9. [DOI: 10.1007/s00702-019-01987-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
48 Fernandes SS, Koth AP, Parfitt GM, Cordeiro MF, Peixoto CS, Soubhia A, Moreira FP, Wiener CD, Oses JP, Kaszubowski E, Barros DM. Enhanced cholinergic-tone during the stress induce a depressive-like state in mice. Behav Brain Res 2018;347:17-25. [PMID: 29501509 DOI: 10.1016/j.bbr.2018.02.044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
49 Jiang N, Wang H, Huang H, Lv J, Zeng G, Wang Q, Bao Y, Chen Y, Liu X. The Antidepressant-Like Effects of Shen Yuan in a Chronic Unpredictable Mild Stress Rat Model. Front Psychiatry 2021;12:622204. [PMID: 33584387 DOI: 10.3389/fpsyt.2021.622204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Shen Y, Yang X, Li G, Gao J, Liang Y. The change of gut microbiota in MDD patients under SSRIs treatment. Sci Rep 2021;11:14918. [PMID: 34290352 DOI: 10.1038/s41598-021-94481-1] [Reference Citation Analysis]
51 Zheng G, Yang F, Fu T, Tu G, Chen Y, Yao X, Xue W, Zhu F. Computational characterization of the selective inhibition of human norepinephrine and serotonin transporters by an escitalopram scaffold. Phys Chem Chem Phys 2018;20:29513-27. [DOI: 10.1039/c8cp06232c] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 7.3] [Reference Citation Analysis]
52 Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Müller DJ, Parikh SV, Pearson NL, Ravindran AV, Uher R; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Can J Psychiatry 2016;61:540-60. [PMID: 27486148 DOI: 10.1177/0706743716659417] [Cited by in Crossref: 357] [Cited by in F6Publishing: 314] [Article Influence: 71.4] [Reference Citation Analysis]
53 Xiao Y, Luo H, Yang WZ, Zeng Y, Shen Y, Ni X, Shi Z, Zhong J, Liang Z, Fu X, Tu H, Sun W, Shen WL, Hu J, Yang J. A Brain Signaling Framework for Stress-Induced Depression and Ketamine Treatment Elucidated by Phosphoproteomics. Front Cell Neurosci 2020;14:48. [PMID: 32317933 DOI: 10.3389/fncel.2020.00048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
54 Bergmans RS, Wegryn-jones R. Examining associations of food insecurity with major depression among older adults in the wake of the Great Recession. Social Science & Medicine 2020;258:113033. [DOI: 10.1016/j.socscimed.2020.113033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
55 Kroes RA, Nilsson CL. Towards the Molecular Foundations of Glutamatergic-targeted Antidepressants. Curr Neuropharmacol 2017;15:35-46. [PMID: 26955966 DOI: 10.2174/1570159x14666160309114740] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
56 Henter ID, de Sousa RT, Gold PW, Brunoni AR, Zarate CA Jr, Machado-Vieira R. Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression. Expert Rev Clin Pharmacol 2017;10:153-66. [PMID: 27781556 DOI: 10.1080/17512433.2017.1253472] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
57 Zheng G, Xue W, Yang F, Zhang Y, Chen Y, Yao X, Zhu F. Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT1A receptor in the treatment of major depressive disorder. Phys Chem Chem Phys 2017;19:28885-96. [PMID: 29057413 DOI: 10.1039/c7cp05688e] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 9.3] [Reference Citation Analysis]
58 Fronza MG, Brod LMP, Casaril AM, Sacramento M, Alves D, Savegnago L. Computational and biological evidences on the serotonergic involvement of SeTACN antidepressant-like effect in mice. PLoS One 2017;12:e0187445. [PMID: 29091968 DOI: 10.1371/journal.pone.0187445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Svob Strac D, Pivac N, Smolders IJ, Fogel WA, De Deurwaerdere P, Di Giovanni G. Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs. Front Neurosci 2016;10:492. [PMID: 27891070 DOI: 10.3389/fnins.2016.00492] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
60 Selçuk M, Selçuk E. A Case of Unexpected Ecchymosis Associated With a High Dose of Venlafaxine. J Clin Psychopharmacol 2021;41:496-8. [PMID: 34166259 DOI: 10.1097/JCP.0000000000001425] [Reference Citation Analysis]
61 Machado-Vieira R, Henter ID, Zarate CA Jr. New targets for rapid antidepressant action. Prog Neurobiol 2017;152:21-37. [PMID: 26724279 DOI: 10.1016/j.pneurobio.2015.12.001] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 12.7] [Reference Citation Analysis]
62 Bertrand D, Terry AV Jr. The wonderland of neuronal nicotinic acetylcholine receptors. Biochem Pharmacol 2018;151:214-25. [PMID: 29248596 DOI: 10.1016/j.bcp.2017.12.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 15.5] [Reference Citation Analysis]
63 Arnett MG, Muglia LM, Laryea G, Muglia LJ. Genetic Approaches to Hypothalamic-Pituitary-Adrenal Axis Regulation. Neuropsychopharmacology 2016;41:245-60. [PMID: 26189452 DOI: 10.1038/npp.2015.215] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
64 Dandekar MP, Peng T, Mcpherson DD, Quevedo J, Soares JC, Huang S. Intravenous infusion of xenon-containing liposomes generates rapid antidepressant-like effects. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;86:140-9. [DOI: 10.1016/j.pnpbp.2018.03.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
65 Singh T, Goel RK. Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression. Epilepsy & Behavior 2016;61:248-57. [DOI: 10.1016/j.yebeh.2016.05.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
66 Yin Y, Liu X, Liu J, Cai E, Zhao Y, Li H, Zhang L, Li P, Gao Y. The effect of beta-sitosterol and its derivatives on depression by the modification of 5-HT, DA and GABA-ergic systems in mice. RSC Adv 2018;8:671-80. [DOI: 10.1039/c7ra11364a] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
67 Sanchez C, El Khoury A, Hassan M, Wegener G, Mathé AA. Sex-dependent behavior, neuropeptide profile and antidepressant response in rat model of depression. Behav Brain Res 2018;351:93-103. [PMID: 29857028 DOI: 10.1016/j.bbr.2018.05.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
68 Matraszek-Gawron R, Chwil M, Terlecka P, Skoczylas MM. Recent Studies on Anti-Depressant Bioactive Substances in Selected Species from the Genera Hemerocallis and Gladiolus: A Systematic Review. Pharmaceuticals (Basel) 2019;12:E172. [PMID: 31775329 DOI: 10.3390/ph12040172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
69 Tolahunase MR, Sagar R, Faiq M, Dada R. Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: A randomized controlled trial. RNN 2018;36:423-42. [DOI: 10.3233/rnn-170810] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
70 Bergmans RS, Larson P, Bennion E, Mezuk B, Wozniak MC, Steiner AL, Gronlund CJ. Short-term exposures to atmospheric evergreen, deciduous, grass, and ragweed aeroallergens and the risk of suicide in Ohio, 2007-2015: Exploring disparities by age, gender, and education level. Environ Res 2021;200:111450. [PMID: 34102161 DOI: 10.1016/j.envres.2021.111450] [Reference Citation Analysis]
71 Chávez-Castillo M, Núñez V, Nava M, Ortega Á, Rojas M, Bermúdez V, Rojas-Quintero J. Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines. Adv Pharmacol Sci 2019;2019:7943481. [PMID: 30719038 DOI: 10.1155/2019/7943481] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
72 Wei Q, Zhou W, Zheng J, Li D, Wang M, Feng L, Huang W, Yang N, Han M, Ma X, Liu Y. Antidepressant effects of 3-(3,4-methylenedioxy-5-trifluoromethyl phenyl)-2E-propenoic acid isobutyl amide involve TSPO-mediated mitophagy signalling pathway. Basic Clin Pharmacol Toxicol 2020;127:380-8. [PMID: 32511877 DOI: 10.1111/bcpt.13452] [Reference Citation Analysis]
73 Andersen J, Ladefoged LK, Wang D, Kristensen TN, Bang-Andersen B, Kristensen AS, Schiøtt B, Strømgaard K. Binding of the multimodal antidepressant drug vortioxetine to the human serotonin transporter. ACS Chem Neurosci 2015;6:1892-900. [PMID: 26389667 DOI: 10.1021/acschemneuro.5b00225] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
74 Atone J, Wagner K, Hashimoto K, Hammock BD. Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases. Prostaglandins Other Lipid Mediat 2020;147:106385. [PMID: 31698143 DOI: 10.1016/j.prostaglandins.2019.106385] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
75 Gill H, Gill B, Chen-li D, El-halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, Mcintyre RS. The emerging role of psilocybin and MDMA in the treatment of mental illness. Expert Review of Neurotherapeutics 2020;20:1263-73. [DOI: 10.1080/14737175.2020.1826931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Tosh DK, Ciancetta A, Mannes P, Warnick E, Janowsky A, Eshleman AJ, Gizewski E, Brust TF, Bohn LM, Auchampach JA, Gao ZG, Jacobson KA. Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists. ACS Omega 2018;3:12658-78. [PMID: 30411015 DOI: 10.1021/acsomega.8b01237] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
77 Mantas I, Saarinen M, Xu ZD, Svenningsson P. Update on GPCR-based targets for the development of novel antidepressants. Mol Psychiatry 2021. [PMID: 33589739 DOI: 10.1038/s41380-021-01040-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Michael JA, Kaur M. The Heart-Brain Connection in Depression: Can it inform a personalised approach for repetitive transcranial magnetic stimulation (rTMS) treatment? Neurosci Biobehav Rev 2021;127:136-43. [PMID: 33891972 DOI: 10.1016/j.neubiorev.2021.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Kobayashi N, Takano M. Aripiprazole-induced sleep-related eating disorder: a case report. J Med Case Rep 2018;12:91. [PMID: 29622043 DOI: 10.1186/s13256-018-1622-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
80 Rahman SU, Ali T, Hao Q, He K, Li W, Ullah N, Zhang Z, Jiang Y, Li S. Xanthohumol Attenuates Lipopolysaccharide-Induced Depressive Like Behavior in Mice: Involvement of NF-κB/Nrf2 Signaling Pathways. Neurochem Res 2021. [PMID: 34398408 DOI: 10.1007/s11064-021-03396-w] [Reference Citation Analysis]
81 Salagre E, Grande I, Solé B, Sanchez-moreno J, Vieta E. Vortioxetine: A new alternative for the treatment of major depressive disorder. Revista de Psiquiatría y Salud Mental (English Edition) 2018;11:48-59. [DOI: 10.1016/j.rpsmen.2018.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
82 Abdul Shukkoor MS, Baharuldin MTHB, Mat Jais AM, Mohamad Moklas MA, Fakurazi S, Basir R. Antidepressant-Like Effect of Lipid Extract of Channa striatus in Postpartum Model of Depression in Rats. Evid Based Complement Alternat Med 2017;2017:1469209. [PMID: 29317891 DOI: 10.1155/2017/1469209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
83 Khalid S, Williams CM, Reynolds SA. Is there an association between diet and depression in children and adolescents? A systematic review. Br J Nutr 2016;116:2097-108. [PMID: 28093091 DOI: 10.1017/S0007114516004359] [Cited by in Crossref: 85] [Cited by in F6Publishing: 42] [Article Influence: 21.3] [Reference Citation Analysis]
84 Papanikolaou N, Pavlopoulos GA, Theodosiou T, Vizirianakis IS, Iliopoulos I. DrugQuest - a text mining workflow for drug association discovery. BMC Bioinformatics 2016;17 Suppl 5:182. [PMID: 27295093 DOI: 10.1186/s12859-016-1041-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
85 Wang XL, Feng ST, Wang YT, Chen NH, Wang ZZ, Zhang Y. Paeoniflorin: A neuroprotective monoterpenoid glycoside with promising anti-depressive properties. Phytomedicine 2021;90:153669. [PMID: 34334273 DOI: 10.1016/j.phymed.2021.153669] [Reference Citation Analysis]
86 Lichtstein D, Ilani A, Rosen H, Horesh N, Singh SV, Buzaglo N, Hodes A. Na⁺, K⁺-ATPase Signaling and Bipolar Disorder. Int J Mol Sci 2018;19:E2314. [PMID: 30087257 DOI: 10.3390/ijms19082314] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
87 Marwari S, Poulsen A, Shih N, Lakshminarayanan R, Kini RM, Johannes CW, Dymock BW, Dawe GS. Intranasal administration of a stapled relaxin-3 mimetic has anxiolytic- and antidepressant-like activity in rats. Br J Pharmacol 2019;176:3899-923. [PMID: 31220339 DOI: 10.1111/bph.14774] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
88 Ilieva K, Tchekalarova J, Atanasova D, Kortenska L, Atanasova M. Antidepressant agomelatine attenuates behavioral deficits and concomitant pathology observed in streptozotocin-induced model of Alzheimer's disease in male rats. Hormones and Behavior 2019;107:11-9. [DOI: 10.1016/j.yhbeh.2018.11.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
89 Jia D, Dou Y, He Y, Zhou X, Gao Y, Ma M, Wu Z, Li W. Saponin extract of Baihe - Zhimu Tang ameliorates depression in chronic mild stress rats. Journal of Functional Foods 2020;68:103905. [DOI: 10.1016/j.jff.2020.103905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Cao B, Park C, Rosenblat JD, Chen Y, Iacobucci M, Subramaniapillai M, Mansur RB, Zuckerman H, Lee Y, Mcintyre RS. Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial. J Psychopharmacol 2019;33:1388-94. [DOI: 10.1177/0269881119874485] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
91 Stephens I. Medical Yoga Therapy. Children (Basel) 2017;4:E12. [PMID: 28208599 DOI: 10.3390/children4020012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
92 Gill H, Gill B, El‐halabi S, Chen‐li D, Lipsitz O, Rosenblat JD, Van Rheenen TE, Rodrigues NB, Mansur RB, Majeed A, Lui LMW, Nasri F, Lee Y, Mcintyre RS. Antidepressant Medications and Weight Change: A Narrative Review. Obesity 2020;28:2064-72. [DOI: 10.1002/oby.22969] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
93 Lee EH, Han PL. Reciprocal interactions across and within multiple levels of monoamine and cortico-limbic systems in stress-induced depression: A systematic review. Neurosci Biobehav Rev 2019;101:13-31. [PMID: 30917923 DOI: 10.1016/j.neubiorev.2019.03.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
94 Mo X, Li Y, Zhu X, Li X, Zhou H, Bi X, Li J. Vortioxetine Derivatives with Amino Acid as Promoiety: Synthesis, Activity, Stability and Preliminary Pharmacokinetic Study. J Pharm Sci 2021;110:3011-9. [PMID: 33891948 DOI: 10.1016/j.xphs.2021.04.011] [Reference Citation Analysis]
95 Mihailescu-Marin MM, Mosoiu DV, Burtea V, Sechel G, Rogozea LM, Ciurescu D. Common Pathways for Pain and Depression-Implications for Practice. Am J Ther 2020;27:e468-76. [PMID: 32897982 DOI: 10.1097/MJT.0000000000001235] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Zabegalov KN, Kolesnikova TO, Khatsko SL, Volgin AD, Yakovlev OA, Amstislavskaya TG, Alekseeva PA, Meshalkina DA, Friend AJ, Bao W, Demin KA, Gainetdinov RR, Kalueff AV. Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models. European Journal of Pharmacology 2018;829:129-40. [DOI: 10.1016/j.ejphar.2018.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
97 Bedse G, Bluett RJ, Patrick TA, Romness NK, Gaulden AD, Kingsley PJ, Plath N, Marnett LJ, Patel S. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors. Transl Psychiatry 2018;8:92. [PMID: 29695817 DOI: 10.1038/s41398-018-0141-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
98 Rostamian A, Gharedaghi A, Norouzi-Javidan A, Dehpour AR. Involvement of the nitric oxide pathway in the anti-depressant-like effects of thalidomide in mice. Physiol Behav 2019;208:112572. [PMID: 31175889 DOI: 10.1016/j.physbeh.2019.112572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
99 Gong W, Zhou Y, Gong W, Qin X. Coniferyl ferulate exerts antidepressant effect via inhibiting the activation of NMDAR-CaMKII-MAPKs and mitochondrial apoptotic pathways. Journal of Ethnopharmacology 2020;251:112533. [DOI: 10.1016/j.jep.2019.112533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
100 Levy MJF, Boulle F, Emerit MB, Poilbout C, Steinbusch HWM, Van den Hove DLA, Kenis G, Lanfumey L. 5-HTT independent effects of fluoxetine on neuroplasticity. Sci Rep 2019;9:6311. [PMID: 31004120 DOI: 10.1038/s41598-019-42775-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
101 Ren Y, Yang CH, Li ZM, Yang Z, Xiao ZJ, Duan JJ, Zhou T, Xu F. Chronic Stress Disturbs Metabolome of Blood Plasma and Urine in Diabetic Rats. Front Psychiatry 2018;9:525. [PMID: 30405462 DOI: 10.3389/fpsyt.2018.00525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
102 Liu Y, Tang W, Ji C, Gu J, Chen Y, Huang J, Zhao X, Sun Y, Wang C, Guan W, Liu J, Jiang B. The Selective SIK2 Inhibitor ARN-3236 Produces Strong Antidepressant-Like Efficacy in Mice via the Hippocampal CRTC1-CREB-BDNF Pathway. Front Pharmacol 2020;11:624429. [PMID: 33519490 DOI: 10.3389/fphar.2020.624429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Fang J, Luo Y, Jin S, Yuan K, Guo Y. Ameliorative effect of anthocyanin on depression mice by increasing monoamine neurotransmitter and up-regulating BDNF expression. Journal of Functional Foods 2020;66:103757. [DOI: 10.1016/j.jff.2019.103757] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
104 Zheng Y, He J, Guo L, Yao L, Zheng X, Yang Z, Xia Y, Wu X, Su Y, Xu N, Chen Y. Transcriptome Analysis on Maternal Separation Rats With Depression-Related Manifestations Ameliorated by Electroacupuncture. Front Neurosci 2019;13:314. [PMID: 31024237 DOI: 10.3389/fnins.2019.00314] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
105 Zhang H, Zhao H, Yang X, Xue Q, Cotten JF, Feng HJ. 5-Hydroxytryptophan, a precursor for serotonin synthesis, reduces seizure-induced respiratory arrest. Epilepsia 2016;57:1228-35. [PMID: 27302625 DOI: 10.1111/epi.13430] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
106 Di Giovanni G, Svob Strac D, Sole M, Unzeta M, Tipton KF, Mück-Šeler D, Bolea I, Della Corte L, Nikolac Perkovic M, Pivac N, Smolders IJ, Stasiak A, Fogel WA, De Deurwaerdère P. Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases. Front Neurosci 2016;10:541. [PMID: 27932945 DOI: 10.3389/fnins.2016.00541] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
107 Tian L, Pu J, Liu Y, Gui S, Zhong X, Song X, Xu S, Zhang H, Wang H, Zhou W, Xie P. Metabolomic analysis of animal models of depression. Metab Brain Dis 2020;35:979-90. [PMID: 32440806 DOI: 10.1007/s11011-020-00574-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
108 Szczypiński JJ, Gola M. Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia? Rev Neurosci 2018;29:727-44. [PMID: 29573379 DOI: 10.1515/revneuro-2017-0091] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
109 Bergmans RS, Smith J. Associations of mental health and chronic physical illness during childhood with major depression in later life. Aging Ment Health 2021;:1-8. [PMID: 34353181 DOI: 10.1080/13607863.2021.1958143] [Reference Citation Analysis]
110 Farooq RK, Tanti A, Ainouche S, Roger S, Belzung C, Camus V. A P2X7 receptor antagonist reverses behavioural alterations, microglial activation and neuroendocrine dysregulation in an unpredictable chronic mild stress (UCMS) model of depression in mice. Psychoneuroendocrinology 2018;97:120-30. [DOI: 10.1016/j.psyneuen.2018.07.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
111 Rocha A, Hart N, Trujillo KA. Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration. Pharmacol Biochem Behav 2017;157:24-34. [PMID: 28442368 DOI: 10.1016/j.pbb.2017.04.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]